| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $48.7M | -6.2% |
| Cost of Revenue | $29.2M | -3.0% |
| Gross Profit | $19.5M | -10.6% |
| R&D Expense | $5.4M | -20.2% |
| SG&A Expense | $9.8M | +11.8% |
| Operating Income | -$8.3M | +17.0% |
| Interest Expense | $146K | — |
| Pre-tax Income | -$8.8M | +6.7% |
| Income Tax | $68K |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.4M | -66.1% |
| Accounts Receivable | $6.0M | -11.5% |
| Inventory | $10.8M | +9.2% |
| Current Assets | $23.6M | -14.2% |
| Total Assets | $29.1M | -15.4% |
| Current Liabilities | $16.6M | +27.6% |
| Long-term Debt | $1.0M | — |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.3M | -8.0% |
| Capital Expenditures | $13K | -88.1% |
| Investing Cash Flow | -$13K | +88.1% |
| Financing Cash Flow | $2.6M | — |
| Free Cash Flow | -$7.3M | -6.5% |
| -24.4% |
| Net Income | -$8.9M | +6.9% |
| EPS (Basic) | -$0.54 | +8.5% |
| EPS (Diluted) | -$0.54 | +8.5% |
| Total Liabilities |
| $27.0M |
| +8.5% |
| Stockholders' Equity | $2.1M | -78.0% |